Niagen Bioscience, Inc.
NAGE
$2.63-2.23%
End of day · as of Oct 13, 2026, 7:45 AM ET
Mkt cap
$836.53M
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
$129.42M
EPS (TTM)
$0.19
Gross Margin (FY2025)
64.28%
Profit Margin (FY2025)
13.43%
Beta
1.95
Div yield
N/A
Sector
Healthcare
Niagen Bioscience, Inc. (NAGE) is a biotechnology company listed on US.
Latest reported NAGE revenue for 2025-12-31 was $129.4M. Net income was $17.4M. Revenue was up 29.9% from 2024-12-31 to 2025-12-31. NAGE currently screens at market cap $836.5M.
Use this NAGE research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full NAGE income, balance, and cash tables.
Niagen Bioscience, Inc. (NAGE) is a biotechnology company in the Healthcare sector.
Latest cached Niagen Bioscience, Inc. (NAGE) revenue for Dec 31, 2025 was $129.4M. Net income was $17.4M. Statements: https://lician.com/financials/nage
Niagen Bioscience, Inc. (NAGE) market capitalization is $836.5M on the latest cached snapshot.
Niagen Bioscience, Inc. (NAGE) cached previous close $2.69; day range $2.63 – $2.67; volume 407,077. Session quote: https://lician.com/quote/nage
Niagen Bioscience, Inc. (NAGE) latest cached earnings event is "NAGE earnings" on Aug 5, 2026. Earnings calendar: https://lician.com/earnings
The latest cached NAGE filing is 8-K · Jun 29, 2026. Filings: https://lician.com/sec/nage